Page 771 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 771

CHAPTER 33  Hematopoietic Tumors  749



                                   1.000

  VetBooks.ir                      .8750
                                   .7500
                                  Proportion surviving  .6250


                                   .5000
                                   .3750

                                   .2500

                                   .1250

                                   0.000
                                       0    120  240  360  480  600   720  840  960  1080  1200
                                                        Days from start of treatment
                           • Fig. 33.30  Survival curve of 37 dogs with multiple myeloma treated with chemotherapy. The median
                           survival time (MST) is 540 days. (From Matus RE, Leifer CE, MacEwen EG, et al. Prognostic factors for
                           multiple myeloma in the dog. J Am Vet Med Assoc. 1986;188:1288-1292.)


            TABLE 33.17     Classification of Multiple Myeloma in
                        Cats Based on Clinical and Diagnostic
                        Criteria Suspected of Predicting
                        Prognosis 770
             Behavior Category  Criteria
             Aggressive        Hypercalcemia, presence of bony lesions
                                 with pathologic fracture, low packed cell
                                 volume (PCV), presence of light-chain
                                 Bence Jones protein in urine, azotemia,
                                 hypercreatinemia, persistence of high
                                 serum protein level after 8 weeks of
                                 treatment, little or no clinical improve-
                                 ment
             Less aggressive   Normal serum calcium, normal creatinine,
                                 blood urea nitrogen, PCV levels, pres-
                                 ence of bony lesions without patho-
                                 logic fractures, absence of light-chain
                                 Bence Jones protein, normalization of
                                 serum protein level after 8 weeks of
                                 treatment.

                                                                     • Fig. 33.31  A cutaneous plasmacytoma on the limb of a dog.

           Solitary and Extramedullary Plasmacytic               (9%; Fig. 33.32), and the gastrointestinal tract (4%). The skin of
           Tumors                                                the limbs and head (including the ears) are the most frequently
                                                                 reported cutaneous sites. 783  Oral plasmacytoma represents 5% of
           Solitary collections of monoclonal plasmacytic tumors can origi-  oral tumors, 2% of lingual tumors, and approximately 20% of
           nate in soft tissues or bone and are referred to as extramedullary   all EMPs. 853  Other EMP sites uncommonly encountered include
           plasmacytoma (EMP) and  solitary osseous plasmacytoma (SOP),   spleen, genitalia, eye, uterus, liver, larynx, trachea, third eyelid,
           respectively. The systemic, multicentric, biologically aggres-  sinonasal cavity (one case reported in the cat 862 ), and intracranial
           sive EMP syndrome encountered in cats has been discussed in   sites. 863–871  The American cocker spaniel, English cocker spaniel,
           the MM section and will only receive limited discussion in this   and  West Highland white terrier (and perhaps  Yorkshire terri-
           section. 771,786   A number  of large  case  compilations  of  cutane-  ers, boxers, German shepherds, and Airedale terriers) have been
           ous plasmacytoma have been reported in the dog. 774,783,850–861    reported inconsistently to be at increased risk for developing plas-
           The most common locations for EMP in the dog are cutaneous   macytomas and the median age of affected dogs is 9 to 10 years
           (86%; Fig. 33.31), mucous membranes of the oral cavity and lips   of age. 783,853
   766   767   768   769   770   771   772   773   774   775   776